Livzon Pharmac Grp Stock Target Price
| LP6 Stock | EUR 3.40 0.18 5.59% |
LIVZON PHARMAC GRP fundamentals help investors to digest information that contributes to LIVZON PHARMAC's financial success or failures. It also enables traders to predict the movement of LIVZON Stock. The fundamental analysis module provides a way to measure LIVZON PHARMAC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LIVZON PHARMAC stock.
LIVZON |
LIVZON Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LIVZON PHARMAC's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LIVZON PHARMAC could also be used in its relative valuation, which is a method of valuing LIVZON PHARMAC by comparing valuation metrics of similar companies.LIVZON PHARMAC is currently under evaluation in target price category among its peers.
LIVZON Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0514 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.15 % | |||
| Shares Outstanding | 309.83 M | |||
| Shares Owned By Insiders | 52.73 % | |||
| Shares Owned By Institutions | 14.83 % | |||
| Price To Earning | 4.02 X | |||
| Revenue | 12.18 B | |||
| Gross Profit | 7.75 B | |||
| EBITDA | 2.3 B | |||
| Net Income | 684.16 M | |||
| Cash And Equivalents | 1.14 B | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 22.97 M | |||
| Debt To Equity | 1.30 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 14.37 X | |||
| Cash Flow From Operations | 192.47 M | |||
| Earnings Per Share | 0.27 X | |||
| Number Of Employees | 8.58 K | |||
| Beta | 0.51 | |||
| Market Capitalization | 3.86 B | |||
| Annual Yield | 0.06 % | |||
| Last Dividend Paid | 1.3 |
About LIVZON PHARMAC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LIVZON PHARMAC GRP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LIVZON PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LIVZON PHARMAC GRP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in LIVZON Stock
LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.